- £66.28bn
- £78.56bn
- £30.33bn
- 87
- 47
- 95
- 92
REG - GSK PLC - US FDA approves GSK’s RSV vaccine for older adults
AnnouncementREG - GSK PLC Allergy Therapeutics - Form 8.3 - Allergy Therapeutics plc
AnnouncementRCS - Harte Hanks, Inc - Harte Hanks Reports 2023 First Quarter Results
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementRCS - Envision Pharma Grp - Envision Pharma Group Appoints Mike Glover to SVP
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK RSV OA vaccine gains positive EMA CHMP opinion
AnnouncementREG - GSK PLC - 1st Quarter Results
AnnouncementREG - GSK PLC - EMA validates Jemperli filing for new indication
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK reaches agreement to acquire BELLUS Health Inc
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Gepotidacin positive phase III data
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Positive phase III RUBY results for Jemperli
AnnouncementREG - GSK PLC - Publication of 2023 AGM Notice
AnnouncementREG - GSK PLC - Statement: Zantac (ranitidine) litigation
Announcement